Editorial · 28 Jan 2025
Short communicationPublished 28 Sep 2020
Amenorrea: guidelines and practice
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem.Amenorrhea is the absence of menstrual bleeding as a result from a number of different conditions. The purpose of this study is to describe the guidelines for the diagnosis and treatment of different types of amenorrhea and relate the major recommendations for the patient management. The ESHRE/ESGE classification system of female genital anomalies (2013) is recommendedto use in cases with amenorrhea due to Congenital malformations of the female genital tract. Turner syndrome is usually accompanied by hypergonadotropichypogonadism and primary or secondary amenorrhea. Estrogen replacement should start between 11 and 12 years of age increasing to adult dosing over 2–3 years, and adding progesterone once breakthrough bleeding occurs or after 2 years of estrogen treatment (European Society of Endocrinology Guidelines, 2017). Functional hypothalamic amenorrhea (FHA) is a form of chronic anovulation, not due to identifiable organic causes, but often associated with stress, weight loss, excessive exercise, or a combination thereof. FHA is a diagnosis of exclusion. 1-stline of therapy is to correct the energy imbalance to improve hypothalamic–pituitary–ovarian axis function, psychological support. 2-nd linefor adolescents and women who have not had return of menses: short-term use of transdermal E2 therapy with cyclic oral progestin (not oral contraceptives or ethinyl E2) (Endocrine Society Guideline, 2017). Premature ovarian insufficiency is characterised by menstrual disturbance (oligo/amenorrhea) with raised gonadotropins and low estradiolbefore the age of 40. Diagnostic criteria of ESHRE Guideline (2015) are: oligo/amenorrhea for at least 4 months, and an elevated FSH level >25 IU/l on two occasions >4 weeks apart. The chance of spontaneous pregnancy is small, but oocyte donation is an established option for fertility. HRT is indicated for the treatment of estrogen deficiency symptoms and to reduce futurerisk of cardiovascular disease, cognitive impairment, reduced bone mineral density.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 31 Aug 2020
Amenorrhea: Guidelines and practice
Short communication · 29 May 2023
Ultrasound in Obstetrics and Gynecology: A Practical Approach to Foetal and Maternal Medicine
Review article · 28 Sep 2018
Hazards and consequences of non-ergonomic working postures in obstetric/gynecologic practice and the manner of relieving them
Research article · 13 May 2014
Survey of Obstetrics and Gynecology Providers on Management of HIVSerodiscordant Couples:Assessment of Attitudes,Practices, and Knowledge
More from this journal
The newest in Gynecology and Reproductive Endocrinology.
Commentary · 20 Jun 2025
Human Papillomavirus (HPV) vaccination: Efficacy, safety and public health impact.
Mini review · 28 May 2025
Adolescent Sexual Health Education: Empowering Youth for a Healthier Future
Rapid communication · 28 May 2025
Gynecologic Care for All Genders: Bridging Gaps in Inclusive Healthcare
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalGynecology and Reproductive Endocrinology
- SubjectReproductive Medicine & Gynaecology
- BylineArticles whose byline prints “Tatiana Belokrinitskaya”

